Joseph Chang is a Global Editor at ICIS. He covers a range of topics including regional interest and world news, with a focus on the APAC region, energy, and mining sectors, as well as business leaders and market trends. Joseph's work has been featured in ComingSoon, Plastics & Rubber Asia Ltd, and the Cureus Journal of Medical Science.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Joseph Chang's coverage is heavily focused on the chemical industry, with particular attention to company-specific updates and market trends. His articles primarily feature press releases and expert commentary related to business, manufacturing, and finance within the chemical sector.
Given this focus, Joseph would likely be interested in receiving pitches from professionals with in-depth knowledge of the global chemical industry, including executives or experts who can provide valuable insights into market trends, company strategies, and innovations in manufacturing processes such as plastics recycling.
As his coverage encompasses a wide range of topics within the chemical industry - from specific companies like ExxonMobil to broader themes like PE and PP capacity - tailored pitches that address these specific areas while offering unique perspectives or exclusive data may capture Joseph's attention.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Joseph Chang
Joseph Chang 11-Sep-2024 HOUSTON (ICIS)–Several chemical companies are shutting down plants in Louisiana, with others taking other
By: Joseph Chang
Joseph Chang 16-Sep-2024 NEW YORK (ICIS)–It has been a long time coming and there is plenty more time before the chemical industry
Joseph Chang 25-Sep-2024 NEW YORK (ICIS)–The lack of a meaningful recovery in volumes amid a weak macroeconomic backdrop along with
By: Joseph Chang
Joseph Chang 20-Nov-2024 CARTAGENA, Colombia (ICIS)–Mexico's nearshoring trend will continue, even with the prospect of changes with
By: Joseph Chang
Momentum is building in the zero-to-low carbon chemicals and plastics space with many different pathways to production that will give customers more options to reduce their carbon footprint.
Joseph Chang 02-Dec-2024 NEW YORK (ICIS)–The ISM US Manufacturing Purchasing Managers' Index (PMI) improved to 48.4 in November – up
By: Joseph Chang
Joseph Chang 05-Dec-2024 PARIS (ICIS)–Global specialty chemicals producer Arkema aims to supercharge growth in key targeted markets
Joseph Chang 13-Dec-2024 NEW YORK (ICIS)–The American Chemistry Council (ACC) expects a 1.9% rebound in chemical volumes in 2025
By: Joseph Chang, Joseph Kraft, Mimi Biswas, Napatkamon Ayutyanont, Christian Vandeveer, Magnus , Javad Savoj, Rajesh Gulati, To, Christian Vandever
Background: Methamphetamine abuse is a public health problem across the world, and the cardiovascular system experiences a significant effect on the myocardium over time. Methamphetamine is a common cause of heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). The prevalence and risk factors for HFpEF and HFrEF in this patient population remain unclear.Methods: This retrospective case-control study is based on a chart review of patients from 139 Hospital Corporation of America (HCA) community hospitals across the United States from January 2013 to December 2017. Active methamphetamine users were identified based on International Classification of Diseases (ICD) codes and a positive urine drug screen during hospitalization. The total number of patients was then divided into two groups: heart failure (HF) vs. no HF. Then exclusion criteria were applied to remove any possible characteristics that might confound the data. The number of patients left was then analyzed.Results: This study identified 9,518 active methamphetamine users, with 403 patients (4.23%) having HF, 41 having unspecified HF, and 51 having HFpEF only, vs. 311 having HFrEF only, compared to 9,115 in the control group without HF. After exclusion criteria were applied, the HF group had 166 patients, and the control group had 398 patients. Heart failure was significantly higher in men, 65.7% men compared to 34.3% women (adjusted odds ratio (OR): 1.894, p = 0.022). The average ages of HF group patients before exclusion criteria, after exclusion criteria, and in the control group were 52.5 years, 46.5 years, and 42.7 years, respectively. The age difference between the HF group (average 46.5 years old) and the control group (average 42.7 years old) was not statistically significant (adjusted OR: 1.007, p = 0.540). However, the average age of the HFpEF population significantly differs from the HFrEF population, 70.2 years old compared to 47.1 years old, respectively (adjusted OR: 1.053, p = 0.001). Female patients appeared to be more likely to have HFpEF (70.6%) compared to HFrEF (18.9%, adjusted OR: 3.738, p < 0.001).Conclusion: Amongst methamphetamine users who develop HF, men appeared to be affected more compared to women. This difference may stem from the differences in activities between men and women. On the other hand, age appeared to not play a role when viewing the entire HF group as a whole. However, when broken down into reduced and preserved groups, age appeared to play a significant role in the type of HF that methamphetamine users may develop. The HFpEF age in methamphetamine users appeared to follow the trend of the general population age with HFpEF. The HFrEF rate was about six times higher among methamphetamine users, excluding the population with unspecified HF. Higher rates of methamphetamine abuse are prompting further studies and programs to reduce cardiac morbidity and mortality in this group and decrease the burden on health systems.
Joseph Chang 08-Jan-2025 NEW YORK (ICIS)–On Wall Street, hope springs eternal at the beginning of a new year, and especially for sectors that have underperformed in the past year.
(833) 317-6278 
